Sangamo Therapeutics
SGMO
#7145
Rank
$0.35 B
Marketcap
$1.70
Share price
-14.57%
Change (1 day)
169.84%
Change (1 year)

Revenue for Sangamo Therapeutics (SGMO)

Revenue in 2024 (TTM): $12.27 Million USD

According to Sangamo Therapeutics 's latest financial reports the company's current revenue (TTM ) is $12.27 Million USD. In 2023 the company made a revenue of $0.17 Billion USD an increase over the revenue in the year 2022 that were of $0.11 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sangamo Therapeutics from 2000 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $12.27 M-93.03%
2023 $0.17 B58.34%
2022 $0.11 B0.54%
2021 $0.11 B-6.34%
2020 $0.11 B15.39%
2019 $0.10 B21.29%
2018 $84.45 M130.95%
2017 $36.56 M88.6%
2016 $19.38 M-50.96%
2015 $39.53 M-13.8%
2014 $45.87 M90.07%
2013 $24.13 M11.44%
2012 $21.65 M109.86%
2011 $10.31 M-50.4%
2010 $20.8 M-6.23%
2009 $22.18 M37.08%
2008 $16.18 M77.91%
2007 $9.09 M15.38%
2006 $7.88 M217.56%
2005 $2.48 M88.82%
2004 $1.31 M-49.01%
2003 $2.57 M-40.62%
2002 $4.34 M-11.1%
2001 $4.88 M42.3%
2000 $3.43 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$27.80 B 226,364.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.34 B 18,995.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$30.93 B 251,867.09%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.67 B 78,681.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$43.03 B 350,400.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$87.69 B 714,211.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.58 B 20,983.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$62.47 B 508,810.97%๐Ÿ‡บ๐Ÿ‡ธ USA